Trials / Completed
CompletedNCT00372008
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Acrux DDS Pty Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-09-06
- Last updated
- 2008-06-20
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00372008. Inclusion in this directory is not an endorsement.